The global Next-Generation Antibody Drug market was valued at million in 2024 and is projected to reach US$ million by 2032, at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
We have surveyed the Next-Generation Antibody Drug manufacturers, suppliers, distributors, and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Next-Generation Antibody Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Next-Generation Antibody Drug. This report contains market size and forecasts of Next-Generation Antibody Drug in global, including the following market information:
Global Next-Generation Antibody Drug market revenue, 2020-2025, 2026-2032, ($ millions)
Global Next-Generation Antibody Drug market sales, 2020-2025, 2026-2032, (K Units)
Global top five Next-Generation Antibody Drug companies in 2024 (%)
Total Market by Segment:
Global Next-Generation Antibody Drug market, by Type, 2020-2025, 2026-2032 ($ millions) & (K Units)
Global Next-Generation Antibody Drug market segment percentages, by Type, 2024 (%)
Fragment-Based
IgG-Based
Global Next-Generation Antibody Drug market, by Application, 2020-2025, 2026-2032 ($ Millions) & (K Units)
Global Next-Generation Antibody Drug market segment percentages, by Application, 2024 (%)
Cancer
Hemophilia
Other Diseases
Global Next-Generation Antibody Drug market, by region and country, 2020-2025, 2026-2032 ($ millions) & (K Units)
Global Next-Generation Antibody Drug market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Next-Generation Antibody Drug revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Next-Generation Antibody Drug revenues share in global market, 2024 (%)
Key companies Next-Generation Antibody Drug sales in global market, 2020-2025 (estimated), (K Units)
Key companies Next-Generation Antibody Drug sales share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Amgen
Janssen
Sanofi
Pfizer
Johnson & Johnson
AstraZeneca
AbbVie
Lindis Biotech
MacroGenics, Inc
Genmab
Alphamab Oncology
Akeso
Innovent Biologics
Yzy Medical Science & Technology
Outline of Major Chapters:
Chapter 1: Introduces the definition of Next-Generation Antibody Drug, market overview.
Chapter 2: Global Next-Generation Antibody Drug market size in revenue and volume.
Chapter 3: Detailed analysis of Next-Generation Antibody Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Next-Generation Antibody Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Next-Generation Antibody Drug capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Next-Generation Antibody Drug Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global Next-Generation Antibody Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Next-Generation Antibody Drug Overall Market Size
2.1 Global Next-Generation Antibody Drug Market Size: 2024 VS 2032
2.2 Global Next-Generation Antibody Drug Market Size, Prospects & Forecasts: 2020-2032
2.3 Global Next-Generation Antibody Drug Sales: 2020-2032
3 Company Landscape
3.1 Top Next-Generation Antibody Drug Players in Global Market
3.2 Top Global Next-Generation Antibody Drug Companies Ranked by Revenue
3.3 Global Next-Generation Antibody Drug Revenue by Companies
3.4 Global Next-Generation Antibody Drug Sales by Companies
3.5 Global Next-Generation Antibody Drug Price by Manufacturer (2020-2025)
3.6 Top 3 and Top 5 Next-Generation Antibody Drug Companies in Global Market, by Revenue in 2024
3.7 Global Manufacturers Next-Generation Antibody Drug Product Type
3.8 Tier 1, Tier 2, and Tier 3 Next-Generation Antibody Drug Players in Global Market
3.8.1 List of Global Tier 1 Next-Generation Antibody Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Next-Generation Antibody Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 Segment by Type - Global Next-Generation Antibody Drug Market Size Markets, 2024 & 2032
4.1.2 Fragment-Based
4.1.3 IgG-Based
4.2 Segment by Type - Global Next-Generation Antibody Drug Revenue & Forecasts
4.2.1 Segment by Type - Global Next-Generation Antibody Drug Revenue, 2020-2025
4.2.2 Segment by Type - Global Next-Generation Antibody Drug Revenue, 2026-2032
4.2.3 Segment by Type - Global Next-Generation Antibody Drug Revenue Market Share, 2020-2032
4.3 Segment by Type - Global Next-Generation Antibody Drug Sales & Forecasts
4.3.1 Segment by Type - Global Next-Generation Antibody Drug Sales, 2020-2025
4.3.2 Segment by Type - Global Next-Generation Antibody Drug Sales, 2026-2032
4.3.3 Segment by Type - Global Next-Generation Antibody Drug Sales Market Share, 2020-2032
4.4 Segment by Type - Global Next-Generation Antibody Drug Price (Manufacturers Selling Prices), 2020-2032
5 Sights by Application
5.1 Overview
5.1.1 Segment by Application - Global Next-Generation Antibody Drug Market Size, 2024 & 2032
5.1.2 Cancer
5.1.3 Hemophilia
5.1.4 Other Diseases
5.2 Segment by Application - Global Next-Generation Antibody Drug Revenue & Forecasts
5.2.1 Segment by Application - Global Next-Generation Antibody Drug Revenue, 2020-2025
5.2.2 Segment by Application - Global Next-Generation Antibody Drug Revenue, 2026-2032
5.2.3 Segment by Application - Global Next-Generation Antibody Drug Revenue Market Share, 2020-2032
5.3 Segment by Application - Global Next-Generation Antibody Drug Sales & Forecasts
5.3.1 Segment by Application - Global Next-Generation Antibody Drug Sales, 2020-2025
5.3.2 Segment by Application - Global Next-Generation Antibody Drug Sales, 2026-2032
5.3.3 Segment by Application - Global Next-Generation Antibody Drug Sales Market Share, 2020-2032
5.4 Segment by Application - Global Next-Generation Antibody Drug Price (Manufacturers Selling Prices), 2020-2032
6 Sights by Region
6.1 By Region - Global Next-Generation Antibody Drug Market Size, 2024 & 2032
6.2 By Region - Global Next-Generation Antibody Drug Revenue & Forecasts
6.2.1 By Region - Global Next-Generation Antibody Drug Revenue, 2020-2025
6.2.2 By Region - Global Next-Generation Antibody Drug Revenue, 2026-2032
6.2.3 By Region - Global Next-Generation Antibody Drug Revenue Market Share, 2020-2032
6.3 By Region - Global Next-Generation Antibody Drug Sales & Forecasts
6.3.1 By Region - Global Next-Generation Antibody Drug Sales, 2020-2025
6.3.2 By Region - Global Next-Generation Antibody Drug Sales, 2026-2032
6.3.3 By Region - Global Next-Generation Antibody Drug Sales Market Share, 2020-2032
6.4 North America
6.4.1 By Country - North America Next-Generation Antibody Drug Revenue, 2020-2032
6.4.2 By Country - North America Next-Generation Antibody Drug Sales, 2020-2032
6.4.3 United States Next-Generation Antibody Drug Market Size, 2020-2032
6.4.4 Canada Next-Generation Antibody Drug Market Size, 2020-2032
6.4.5 Mexico Next-Generation Antibody Drug Market Size, 2020-2032
6.5 Europe
6.5.1 By Country - Europe Next-Generation Antibody Drug Revenue, 2020-2032
6.5.2 By Country - Europe Next-Generation Antibody Drug Sales, 2020-2032
6.5.3 Germany Next-Generation Antibody Drug Market Size, 2020-2032
6.5.4 France Next-Generation Antibody Drug Market Size, 2020-2032
6.5.5 U.K. Next-Generation Antibody Drug Market Size, 2020-2032
6.5.6 Italy Next-Generation Antibody Drug Market Size, 2020-2032
6.5.7 Russia Next-Generation Antibody Drug Market Size, 2020-2032
6.5.8 Nordic Countries Next-Generation Antibody Drug Market Size, 2020-2032
6.5.9 Benelux Next-Generation Antibody Drug Market Size, 2020-2032
6.6 Asia
6.6.1 By Region - Asia Next-Generation Antibody Drug Revenue, 2020-2032
6.6.2 By Region - Asia Next-Generation Antibody Drug Sales, 2020-2032
6.6.3 China Next-Generation Antibody Drug Market Size, 2020-2032
6.6.4 Japan Next-Generation Antibody Drug Market Size, 2020-2032
6.6.5 South Korea Next-Generation Antibody Drug Market Size, 2020-2032
6.6.6 Southeast Asia Next-Generation Antibody Drug Market Size, 2020-2032
6.6.7 India Next-Generation Antibody Drug Market Size, 2020-2032
6.7 South America
6.7.1 By Country - South America Next-Generation Antibody Drug Revenue, 2020-2032
6.7.2 By Country - South America Next-Generation Antibody Drug Sales, 2020-2032
6.7.3 Brazil Next-Generation Antibody Drug Market Size, 2020-2032
6.7.4 Argentina Next-Generation Antibody Drug Market Size, 2020-2032
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Next-Generation Antibody Drug Revenue, 2020-2032
6.8.2 By Country - Middle East & Africa Next-Generation Antibody Drug Sales, 2020-2032
6.8.3 Turkey Next-Generation Antibody Drug Market Size, 2020-2032
6.8.4 Israel Next-Generation Antibody Drug Market Size, 2020-2032
6.8.5 Saudi Arabia Next-Generation Antibody Drug Market Size, 2020-2032
6.8.6 UAE Next-Generation Antibody Drug Market Size, 2020-2032
7 Manufacturers & Brands Profiles
7.1 Roche
7.1.1 Roche Company Summary
7.1.2 Roche Business Overview
7.1.3 Roche Next-Generation Antibody Drug Major Product Offerings
7.1.4 Roche Next-Generation Antibody Drug Sales and Revenue in Global (2020-2025)
7.1.5 Roche Key News & Latest Developments
7.2 Amgen
7.2.1 Amgen Company Summary
7.2.2 Amgen Business Overview
7.2.3 Amgen Next-Generation Antibody Drug Major Product Offerings
7.2.4 Amgen Next-Generation Antibody Drug Sales and Revenue in Global (2020-2025)
7.2.5 Amgen Key News & Latest Developments
7.3 Janssen
7.3.1 Janssen Company Summary
7.3.2 Janssen Business Overview
7.3.3 Janssen Next-Generation Antibody Drug Major Product Offerings
7.3.4 Janssen Next-Generation Antibody Drug Sales and Revenue in Global (2020-2025)
7.3.5 Janssen Key News & Latest Developments
7.4 Sanofi
7.4.1 Sanofi Company Summary
7.4.2 Sanofi Business Overview
7.4.3 Sanofi Next-Generation Antibody Drug Major Product Offerings
7.4.4 Sanofi Next-Generation Antibody Drug Sales and Revenue in Global (2020-2025)
7.4.5 Sanofi Key News & Latest Developments
7.5 Pfizer
7.5.1 Pfizer Company Summary
7.5.2 Pfizer Business Overview
7.5.3 Pfizer Next-Generation Antibody Drug Major Product Offerings
7.5.4 Pfizer Next-Generation Antibody Drug Sales and Revenue in Global (2020-2025)
7.5.5 Pfizer Key News & Latest Developments
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Company Summary
7.6.2 Johnson & Johnson Business Overview
7.6.3 Johnson & Johnson Next-Generation Antibody Drug Major Product Offerings
7.6.4 Johnson & Johnson Next-Generation Antibody Drug Sales and Revenue in Global (2020-2025)
7.6.5 Johnson & Johnson Key News & Latest Developments
7.7 AstraZeneca
7.7.1 AstraZeneca Company Summary
7.7.2 AstraZeneca Business Overview
7.7.3 AstraZeneca Next-Generation Antibody Drug Major Product Offerings
7.7.4 AstraZeneca Next-Generation Antibody Drug Sales and Revenue in Global (2020-2025)
7.7.5 AstraZeneca Key News & Latest Developments
7.8 AbbVie
7.8.1 AbbVie Company Summary
7.8.2 AbbVie Business Overview
7.8.3 AbbVie Next-Generation Antibody Drug Major Product Offerings
7.8.4 AbbVie Next-Generation Antibody Drug Sales and Revenue in Global (2020-2025)
7.8.5 AbbVie Key News & Latest Developments
7.9 Lindis Biotech
7.9.1 Lindis Biotech Company Summary
7.9.2 Lindis Biotech Business Overview
7.9.3 Lindis Biotech Next-Generation Antibody Drug Major Product Offerings
7.9.4 Lindis Biotech Next-Generation Antibody Drug Sales and Revenue in Global (2020-2025)
7.9.5 Lindis Biotech Key News & Latest Developments
7.10 MacroGenics, Inc
7.10.1 MacroGenics, Inc Company Summary
7.10.2 MacroGenics, Inc Business Overview
7.10.3 MacroGenics, Inc Next-Generation Antibody Drug Major Product Offerings
7.10.4 MacroGenics, Inc Next-Generation Antibody Drug Sales and Revenue in Global (2020-2025)
7.10.5 MacroGenics, Inc Key News & Latest Developments
7.11 Genmab
7.11.1 Genmab Company Summary
7.11.2 Genmab Business Overview
7.11.3 Genmab Next-Generation Antibody Drug Major Product Offerings
7.11.4 Genmab Next-Generation Antibody Drug Sales and Revenue in Global (2020-2025)
7.11.5 Genmab Key News & Latest Developments
7.12 Alphamab Oncology
7.12.1 Alphamab Oncology Company Summary
7.12.2 Alphamab Oncology Business Overview
7.12.3 Alphamab Oncology Next-Generation Antibody Drug Major Product Offerings
7.12.4 Alphamab Oncology Next-Generation Antibody Drug Sales and Revenue in Global (2020-2025)
7.12.5 Alphamab Oncology Key News & Latest Developments
7.13 Akeso
7.13.1 Akeso Company Summary
7.13.2 Akeso Business Overview
7.13.3 Akeso Next-Generation Antibody Drug Major Product Offerings
7.13.4 Akeso Next-Generation Antibody Drug Sales and Revenue in Global (2020-2025)
7.13.5 Akeso Key News & Latest Developments
7.14 Innovent Biologics
7.14.1 Innovent Biologics Company Summary
7.14.2 Innovent Biologics Business Overview
7.14.3 Innovent Biologics Next-Generation Antibody Drug Major Product Offerings
7.14.4 Innovent Biologics Next-Generation Antibody Drug Sales and Revenue in Global (2020-2025)
7.14.5 Innovent Biologics Key News & Latest Developments
7.15 Yzy Medical Science & Technology
7.15.1 Yzy Medical Science & Technology Company Summary
7.15.2 Yzy Medical Science & Technology Business Overview
7.15.3 Yzy Medical Science & Technology Next-Generation Antibody Drug Major Product Offerings
7.15.4 Yzy Medical Science & Technology Next-Generation Antibody Drug Sales and Revenue in Global (2020-2025)
7.15.5 Yzy Medical Science & Technology Key News & Latest Developments
8 Global Next-Generation Antibody Drug Production Capacity, Analysis
8.1 Global Next-Generation Antibody Drug Production Capacity, 2020-2032
8.2 Next-Generation Antibody Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Next-Generation Antibody Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Next-Generation Antibody Drug Supply Chain Analysis
10.1 Next-Generation Antibody Drug Industry Value Chain
10.2 Next-Generation Antibody Drug Upstream Market
10.3 Next-Generation Antibody Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Next-Generation Antibody Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Next-Generation Antibody Drug in Global Market
Table 2. Top Next-Generation Antibody Drug Players in Global Market, Ranking by Revenue (2024)
Table 3. Global Next-Generation Antibody Drug Revenue by Companies, (US$, Mn), 2020-2025
Table 4. Global Next-Generation Antibody Drug Revenue Share by Companies, 2020-2025
Table 5. Global Next-Generation Antibody Drug Sales by Companies, (K Units), 2020-2025
Table 6. Global Next-Generation Antibody Drug Sales Share by Companies, 2020-2025
Table 7. Key Manufacturers Next-Generation Antibody Drug Price (2020-2025) & (US$/Unit)
Table 8. Global Manufacturers Next-Generation Antibody Drug Product Type
Table 9. List of Global Tier 1 Next-Generation Antibody Drug Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Next-Generation Antibody Drug Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segment by Type � Global Next-Generation Antibody Drug Revenue, (US$, Mn), 2024 & 2032
Table 12. Segment by Type - Global Next-Generation Antibody Drug Revenue (US$, Mn), 2020-2025
Table 13. Segment by Type - Global Next-Generation Antibody Drug Revenue (US$, Mn), 2026-2032
Table 14. Segment by Type - Global Next-Generation Antibody Drug Sales (K Units), 2020-2025
Table 15. Segment by Type - Global Next-Generation Antibody Drug Sales (K Units), 2026-2032
Table 16. Segment by Application � Global Next-Generation Antibody Drug Revenue, (US$, Mn), 2024 & 2032
Table 17. Segment by Application - Global Next-Generation Antibody Drug Revenue, (US$, Mn), 2020-2025
Table 18. Segment by Application - Global Next-Generation Antibody Drug Revenue, (US$, Mn), 2026-2032
Table 19. Segment by Application - Global Next-Generation Antibody Drug Sales, (K Units), 2020-2025
Table 20. Segment by Application - Global Next-Generation Antibody Drug Sales, (K Units), 2026-2032
Table 21. By Region � Global Next-Generation Antibody Drug Revenue, (US$, Mn), 2025-2032
Table 22. By Region - Global Next-Generation Antibody Drug Revenue, (US$, Mn), 2020-2025
Table 23. By Region - Global Next-Generation Antibody Drug Revenue, (US$, Mn), 2026-2032
Table 24. By Region - Global Next-Generation Antibody Drug Sales, (K Units), 2020-2025
Table 25. By Region - Global Next-Generation Antibody Drug Sales, (K Units), 2026-2032
Table 26. By Country - North America Next-Generation Antibody Drug Revenue, (US$, Mn), 2020-2025
Table 27. By Country - North America Next-Generation Antibody Drug Revenue, (US$, Mn), 2026-2032
Table 28. By Country - North America Next-Generation Antibody Drug Sales, (K Units), 2020-2025
Table 29. By Country - North America Next-Generation Antibody Drug Sales, (K Units), 2026-2032
Table 30. By Country - Europe Next-Generation Antibody Drug Revenue, (US$, Mn), 2020-2025
Table 31. By Country - Europe Next-Generation Antibody Drug Revenue, (US$, Mn), 2026-2032
Table 32. By Country - Europe Next-Generation Antibody Drug Sales, (K Units), 2020-2025
Table 33. By Country - Europe Next-Generation Antibody Drug Sales, (K Units), 2026-2032
Table 34. By Region - Asia Next-Generation Antibody Drug Revenue, (US$, Mn), 2020-2025
Table 35. By Region - Asia Next-Generation Antibody Drug Revenue, (US$, Mn), 2026-2032
Table 36. By Region - Asia Next-Generation Antibody Drug Sales, (K Units), 2020-2025
Table 37. By Region - Asia Next-Generation Antibody Drug Sales, (K Units), 2026-2032
Table 38. By Country - South America Next-Generation Antibody Drug Revenue, (US$, Mn), 2020-2025
Table 39. By Country - South America Next-Generation Antibody Drug Revenue, (US$, Mn), 2026-2032
Table 40. By Country - South America Next-Generation Antibody Drug Sales, (K Units), 2020-2025
Table 41. By Country - South America Next-Generation Antibody Drug Sales, (K Units), 2026-2032
Table 42. By Country - Middle East & Africa Next-Generation Antibody Drug Revenue, (US$, Mn), 2020-2025
Table 43. By Country - Middle East & Africa Next-Generation Antibody Drug Revenue, (US$, Mn), 2026-2032
Table 44. By Country - Middle East & Africa Next-Generation Antibody Drug Sales, (K Units), 2020-2025
Table 45. By Country - Middle East & Africa Next-Generation Antibody Drug Sales, (K Units), 2026-2032
Table 46. Roche Company Summary
Table 47. Roche Next-Generation Antibody Drug Product Offerings
Table 48. Roche Next-Generation Antibody Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 49. Roche Key News & Latest Developments
Table 50. Amgen Company Summary
Table 51. Amgen Next-Generation Antibody Drug Product Offerings
Table 52. Amgen Next-Generation Antibody Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 53. Amgen Key News & Latest Developments
Table 54. Janssen Company Summary
Table 55. Janssen Next-Generation Antibody Drug Product Offerings
Table 56. Janssen Next-Generation Antibody Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 57. Janssen Key News & Latest Developments
Table 58. Sanofi Company Summary
Table 59. Sanofi Next-Generation Antibody Drug Product Offerings
Table 60. Sanofi Next-Generation Antibody Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 61. Sanofi Key News & Latest Developments
Table 62. Pfizer Company Summary
Table 63. Pfizer Next-Generation Antibody Drug Product Offerings
Table 64. Pfizer Next-Generation Antibody Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 65. Pfizer Key News & Latest Developments
Table 66. Johnson & Johnson Company Summary
Table 67. Johnson & Johnson Next-Generation Antibody Drug Product Offerings
Table 68. Johnson & Johnson Next-Generation Antibody Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 69. Johnson & Johnson Key News & Latest Developments
Table 70. AstraZeneca Company Summary
Table 71. AstraZeneca Next-Generation Antibody Drug Product Offerings
Table 72. AstraZeneca Next-Generation Antibody Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 73. AstraZeneca Key News & Latest Developments
Table 74. AbbVie Company Summary
Table 75. AbbVie Next-Generation Antibody Drug Product Offerings
Table 76. AbbVie Next-Generation Antibody Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 77. AbbVie Key News & Latest Developments
Table 78. Lindis Biotech Company Summary
Table 79. Lindis Biotech Next-Generation Antibody Drug Product Offerings
Table 80. Lindis Biotech Next-Generation Antibody Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 81. Lindis Biotech Key News & Latest Developments
Table 82. MacroGenics, Inc Company Summary
Table 83. MacroGenics, Inc Next-Generation Antibody Drug Product Offerings
Table 84. MacroGenics, Inc Next-Generation Antibody Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 85. MacroGenics, Inc Key News & Latest Developments
Table 86. Genmab Company Summary
Table 87. Genmab Next-Generation Antibody Drug Product Offerings
Table 88. Genmab Next-Generation Antibody Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 89. Genmab Key News & Latest Developments
Table 90. Alphamab Oncology Company Summary
Table 91. Alphamab Oncology Next-Generation Antibody Drug Product Offerings
Table 92. Alphamab Oncology Next-Generation Antibody Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 93. Alphamab Oncology Key News & Latest Developments
Table 94. Akeso Company Summary
Table 95. Akeso Next-Generation Antibody Drug Product Offerings
Table 96. Akeso Next-Generation Antibody Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 97. Akeso Key News & Latest Developments
Table 98. Innovent Biologics Company Summary
Table 99. Innovent Biologics Next-Generation Antibody Drug Product Offerings
Table 100. Innovent Biologics Next-Generation Antibody Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 101. Innovent Biologics Key News & Latest Developments
Table 102. Yzy Medical Science & Technology Company Summary
Table 103. Yzy Medical Science & Technology Next-Generation Antibody Drug Product Offerings
Table 104. Yzy Medical Science & Technology Next-Generation Antibody Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 105. Yzy Medical Science & Technology Key News & Latest Developments
Table 106. Next-Generation Antibody Drug Capacity of Key Manufacturers in Global Market, 2023-2025 (K Units)
Table 107. Global Next-Generation Antibody Drug Capacity Market Share of Key Manufacturers, 2023-2025
Table 108. Global Next-Generation Antibody Drug Production by Region, 2020-2025 (K Units)
Table 109. Global Next-Generation Antibody Drug Production by Region, 2026-2032 (K Units)
Table 110. Next-Generation Antibody Drug Market Opportunities & Trends in Global Market
Table 111. Next-Generation Antibody Drug Market Drivers in Global Market
Table 112. Next-Generation Antibody Drug Market Restraints in Global Market
Table 113. Next-Generation Antibody Drug Raw Materials
Table 114. Next-Generation Antibody Drug Raw Materials Suppliers in Global Market
Table 115. Typical Next-Generation Antibody Drug Downstream
Table 116. Next-Generation Antibody Drug Downstream Clients in Global Market
Table 117. Next-Generation Antibody Drug Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Next-Generation Antibody Drug Product Picture
Figure 2. Next-Generation Antibody Drug Segment by Type in 2024
Figure 3. Next-Generation Antibody Drug Segment by Application in 2024
Figure 4. Global Next-Generation Antibody Drug Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global Next-Generation Antibody Drug Market Size: 2024 VS 2032 (US$, Mn)
Figure 7. Global Next-Generation Antibody Drug Revenue: 2020-2032 (US$, Mn)
Figure 8. Next-Generation Antibody Drug Sales in Global Market: 2020-2032 (K Units)
Figure 9. The Top 3 and 5 Players Market Share by Next-Generation Antibody Drug Revenue in 2024
Figure 10. Segment by Type � Global Next-Generation Antibody Drug Revenue, (US$, Mn), 2024 & 2032
Figure 11. Segment by Type - Global Next-Generation Antibody Drug Revenue Market Share, 2020-2032
Figure 12. Segment by Type - Global Next-Generation Antibody Drug Sales Market Share, 2020-2032
Figure 13. Segment by Type - Global Next-Generation Antibody Drug Price (US$/Unit), 2020-2032
Figure 14. Segment by Application � Global Next-Generation Antibody Drug Revenue, (US$, Mn), 2024 & 2032
Figure 15. Segment by Application - Global Next-Generation Antibody Drug Revenue Market Share, 2020-2032
Figure 16. Segment by Application - Global Next-Generation Antibody Drug Sales Market Share, 2020-2032
Figure 17. Segment by Application -Global Next-Generation Antibody Drug Price (US$/Unit), 2020-2032
Figure 18. By Region � Global Next-Generation Antibody Drug Revenue, (US$, Mn), 2025 & 2032
Figure 19. By Region - Global Next-Generation Antibody Drug Revenue Market Share, 2020 VS 2024 VS 2032
Figure 20. By Region - Global Next-Generation Antibody Drug Revenue Market Share, 2020-2032
Figure 21. By Region - Global Next-Generation Antibody Drug Sales Market Share, 2020-2032
Figure 22. By Country - North America Next-Generation Antibody Drug Revenue Market Share, 2020-2032
Figure 23. By Country - North America Next-Generation Antibody Drug Sales Market Share, 2020-2032
Figure 24. United States Next-Generation Antibody Drug Revenue, (US$, Mn), 2020-2032
Figure 25. Canada Next-Generation Antibody Drug Revenue, (US$, Mn), 2020-2032
Figure 26. Mexico Next-Generation Antibody Drug Revenue, (US$, Mn), 2020-2032
Figure 27. By Country - Europe Next-Generation Antibody Drug Revenue Market Share, 2020-2032
Figure 28. By Country - Europe Next-Generation Antibody Drug Sales Market Share, 2020-2032
Figure 29. Germany Next-Generation Antibody Drug Revenue, (US$, Mn), 2020-2032
Figure 30. France Next-Generation Antibody Drug Revenue, (US$, Mn), 2020-2032
Figure 31. U.K. Next-Generation Antibody Drug Revenue, (US$, Mn), 2020-2032
Figure 32. Italy Next-Generation Antibody Drug Revenue, (US$, Mn), 2020-2032
Figure 33. Russia Next-Generation Antibody Drug Revenue, (US$, Mn), 2020-2032
Figure 34. Nordic Countries Next-Generation Antibody Drug Revenue, (US$, Mn), 2020-2032
Figure 35. Benelux Next-Generation Antibody Drug Revenue, (US$, Mn), 2020-2032
Figure 36. By Region - Asia Next-Generation Antibody Drug Revenue Market Share, 2020-2032
Figure 37. By Region - Asia Next-Generation Antibody Drug Sales Market Share, 2020-2032
Figure 38. China Next-Generation Antibody Drug Revenue, (US$, Mn), 2020-2032
Figure 39. Japan Next-Generation Antibody Drug Revenue, (US$, Mn), 2020-2032
Figure 40. South Korea Next-Generation Antibody Drug Revenue, (US$, Mn), 2020-2032
Figure 41. Southeast Asia Next-Generation Antibody Drug Revenue, (US$, Mn), 2020-2032
Figure 42. India Next-Generation Antibody Drug Revenue, (US$, Mn), 2020-2032
Figure 43. By Country - South America Next-Generation Antibody Drug Revenue Market Share, 2020-2032
Figure 44. By Country - South America Next-Generation Antibody Drug Sales, Market Share, 2020-2032
Figure 45. Brazil Next-Generation Antibody Drug Revenue, (US$, Mn), 2020-2032
Figure 46. Argentina Next-Generation Antibody Drug Revenue, (US$, Mn), 2020-2032
Figure 47. By Country - Middle East & Africa Next-Generation Antibody Drug Revenue, Market Share, 2020-2032
Figure 48. By Country - Middle East & Africa Next-Generation Antibody Drug Sales, Market Share, 2020-2032
Figure 49. Turkey Next-Generation Antibody Drug Revenue, (US$, Mn), 2020-2032
Figure 50. Israel Next-Generation Antibody Drug Revenue, (US$, Mn), 2020-2032
Figure 51. Saudi Arabia Next-Generation Antibody Drug Revenue, (US$, Mn), 2020-2032
Figure 52. UAE Next-Generation Antibody Drug Revenue, (US$, Mn), 2020-2032
Figure 53. Global Next-Generation Antibody Drug Production Capacity (K Units), 2020-2032
Figure 54. The Percentage of Production Next-Generation Antibody Drug by Region, 2024 VS 2032
Figure 55. Next-Generation Antibody Drug Industry Value Chain
Figure 56. Marketing Channels
